Tupaz, Edmar .
HRN: 27-77-33 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/09/2025
CEFTRIAXONE 1G (VIAL)
09/09/2025
09/16/2025
IV
1.4kg
Q12
T/c Nephrotic Syndrome Sec To Agn
Checking Initial Appropriateness
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines